Cathal Friel
CATHAL FRIEL has been putting together a group of companies in the clinical research organisation sector. Rather than competing with the multi-billion euro Icon group (which grew out of Austin Darragh’s Institute of Clinical Pharmacology), Open Orphan is instead focused on offering a clinical services business targeting the so-called orphan drug sector. Although it is... Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!
